HP Inc. (0J2E)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 33.75 |
|---|---|
| 52-week range | 17.02 – 36.21 |
| Return, 1 month / 3 months | +7.9% / +28.2% |
| Return, 1 year / 3 years | +22.5% / +42.1% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 45.8% |
| Worst drawdown (1 year) | -34.2% |
| Average daily value traded | 0.93M USD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
HP Inc. is a technology company based in Palo Alto, California, that makes personal computers and printers. Its product range includes laptops, desktop computers, workstations, displays and printers, together with the ink, toner and other supplies that go with them. It serves individual consumers, small businesses, large organisations and public institutions around the world, selling through retailers, distributors and its own channels. The company also provides related services such as device management and printing solutions for commercial customers.
On this site HP Inc. appears as a stock on the London Stock Exchange (UK), code 0J2E, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
HP Inc. (0J2E) trades on the London Stock Exchange in UK. It last closed at USD 33.75 on 27 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,022 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.5% and over the last three months it rose 28.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 38.4% | ||
| From 52-week high | -4.2% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.2% | ||
| 6-month return | 71.5% | ||
| 12-month return, skipping the last month | 13.6% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.2% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.93M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +8.6% |
|---|---|
| 1 month | +7.9% |
| 3 months | +28.2% |
| 6 months | +71.5% |
| 1 year | +22.5% |
| 3 years | +42.1% |
| 5 years | +31.0% |
Signals
| 50-day / 200-day average | 31.63 / 24.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.39 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Dec 2025 | USD 0.3000 |
| 10 Sep 2025 | USD 0.2894 |
| 10 Jun 2025 | USD 0.2894 |
| 11 Mar 2025 | USD 0.2894 |
| 10 Dec 2024 | USD 0.2894 |
| 11 Sep 2024 | USD 0.2756 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.